According to Adaptimmune Therapeutics's latest financial reports the company's current earnings (TTM) are -ยฃ57.53 M. In 2023 the company made an earning of -ยฃ87.11 M an increase over its 2022 earnings that were of -ยฃ0.13 B.The earnings displayed on this page is the company's Pretax Income.